Tolvaptan is effective in treating patients with refractory ascites due to cirrhosis.

Tahara, Toshiyuki; Mori, Kiyoto; Mochizuki, Mari; Ishiyama, Ryoko; Noda, Marin; Hoshi, Hitomi; Lefor, Alan Kawarai; Shinozaki, Satoshi

Tahara, Toshiyuki; Mori, Kiyoto; Mochizuki, Mari; Ishiyama, Ryoko; Noda, Marin; Hoshi, Hitomi; Lefor, Alan Kawarai; Shinozaki, Satoshi.

Afiliación

Tahara T; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi 329-0974, Japan.
Mori K; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi 329-0974, Japan.
Mochizuki M; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi 329-0974, Japan.
Ishiyama R; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi 329-0974, Japan.
Noda M; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi 329-0974, Japan.
Hoshi H; Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi 329-0974, Japan.
Lefor AK; Department of Surgery, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Shinozaki S; Shinozaki Medical Clinic, Utsunomiya, Tochigi 321-3223, Japan.

Biomed Rep ; 7(6): 558-562, 2017 Dec.

Article en En | MEDLINE | ID: mdl-29250327

Palabras clave

ascites; diuretics; glomerular filtration rate; hyponatremia; liver cirrhosis; patient outcome assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomed Rep Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google